BARDA

MediciNova, Inc (NASDAQ: MNOV) shares soared 111% in the regular and after-hours sessions on Tuesday. What Happened: The biopharmaceutical company announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA) to repurpose MN-166 (ibudilast) as a potential medical...

AstraZeneca Plc (NYSE: AZN) announced Monday that its COVID-19 vaccine candidate is moving into phase three clinical trials for all adult age groups in the United States. What Happened:  The development of AZD1222 is already in the late stages of testing in the United...